IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q1 2025 Holdings

Filed 2025-05-15 | 5 holdings | $111.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pharvaris N.V.(PHVS)COMN69605108$69.2M4,410,58162.3%
Maze Therapeutics Inc(MAZE)COM578784100$23.3M2,111,91920.9%
Lyell Immunopharma, Inc.COM55083R104$8.6M16,007,9997.8%
Kura Oncology, Inc.(KURA)COM50127T109$7.3M1,111,8826.6%
Relay Therapeutics Inc.(RLAY)COM75943R102$2.6M1,000,0002.4%